Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT01330056
Eligibility Criteria:
Inclusion Criteria:
* Patients with squamous cell carcinomas arising in the oropharynx, larynx, or hypopharynx
* Resectable tumors without distant metastases
* age range: 18-80 years
* Pretreatment Karnofsky performance scale \> or 70%
* Operable patients
* No significant loss of pretreatment larynx and pharyngeal functions
Exclusion Criteria:
* Patients with a present or previous history of other cancers except benign tumors, premalignant lesions, carcinoma-in-situ (at some organ sites), well-differentiated thyroid carcinoma and low-grade salivary gland cancers (from tumor-board decision whether the tumors significantly affect the survival outcomes)
* Other organ-site cancers
* Low-performance status or non-operable patients
* Non-resectable or distant-metastatic tumors
* Extensive primary or neck nodal diseases
* Significant pretreament loss of laryngeal or pharyngeal functions
* cT1N0 glottic carcinomas
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01330056
Study Brief:
Protocol Section:
NCT01330056